Please use this identifier to cite or link to this item:
Title: Effects of Carvedilol on Isolated Heart Mitochondria: Evidence for a Protonophoretic Mechanism
Authors: Oliveira, Paulo J. 
Marques, M. Paula M. 
Carvalho, Luís A. E. Batista de 
Moreno, A. J. M. 
Keywords: rat heart mitochondria; carvedilol; uncoupler; ab initio SCF-MO calculations
Issue Date: 2000
Citation: Biochemical and Biophysical Research Communications. 276:1 (2000) 82-87
Abstract: Carvedilol ({1-[carbazolyl-(4)-oxy]-3-[2-methoxyphenoxyethyl)amino]-propanol-(2)}) is a novel compound used in clinical practice for the treatment of congestive heart failure, mild to moderate hypertension, and myocardial infarction. Carvedilol was also shown to protect cardiac mitochondria from oxidative stress events. Because mitochondria are the main suppliers of ATP for cardiac muscle work, a study of the effects of carvedilol in mitochondrial bioenergetics is necessary to fully understand the basis of its protective role in myocardial energetics. In this work we show that carvedilol acts as an uncoupler of oxidative phosphorylation, decreasing mitochondrial electric potential ([Delta][Psi]) by a weak protonophoretic mechanism. Theoretical studies were carried out to determine the relevance of conformation and proton affinity of the protonable amino side-chain group in the proton-shuttling activity across the inner mitochondrial membrane. BM910228, a hydroxylated metabolite of carvedilol, was also studied for comparison with the parent compound. Implications for the protective role of carvedilol in heart mitochondrial bioenergetics are discussed.
DOI: 10.1006/bbrc.2000.3374
Rights: openAccess
Appears in Collections:FCTUC Ciências da Vida - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
file665515121d194aee9289b8baad6222ba.pdf89.98 kBAdobe PDFView/Open
Show full item record


checked on Sep 2, 2021

Page view(s)

checked on Oct 5, 2021


checked on Oct 5, 2021

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.